Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 71 points (0.4%) at 16,428 as of Thursday, Dec. 26, 2013, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,679 issues advancing vs. 1,241 declining with 183 unchanged. The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.3%. A company within the industry that increased today was Express Scripts ( ESRX), up 0.9%. TheStreet would like to highlight 4 stocks pushing the industry lower today: 4. Mindray Medical International Limited ADR r ( MR) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mindray Medical International Limited ADR r is down $1.13 (-3.0%) to $36.30 on average volume. Thus far, 428,353 shares of Mindray Medical International Limited ADR r exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $36.30-$37.75 after having opened the day at $37.75 as compared to the previous trading day's close of $37.43. Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International Limited ADR r has a market cap of $4.5 billion and is part of the health care sector. Shares are up 14.5% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Mindray Medical International Limited ADR r a buy, 1 analyst rates it a sell, and 2 rate it a hold. TheStreet Ratings rates Mindray Medical International Limited ADR r as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Mindray Medical International Limited ADR r Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.